QRxPharma
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, QRxPharma sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
QRxPharma: 7 sponsored US clinical trials, none currently recruiting.
QRxPharma sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 5 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postoperative Pain, with 1 trials.
Upper-quartile sponsor footprint
QRxPharma sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients
NCT01280331
Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty
NCT01055015
Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients
NCT01016808
Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty
NCT00818493
Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients
NCT00831051
Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain
NCT00565760
Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain
NCT00560183
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 5 |
Therapeutic Areas
How the QRxPharma archive is shaped
7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).
Phase mix: 5 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Postoperative Pain (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
QRxPharma: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
QRxPharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this QRxPharma page
7 registered trials is a research-attention snapshot, not an endorsement of QRxPharma or any single study.
- None of QRxPharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Postoperative Pain is the condition QRxPharma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postoperative Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
QRxPharma pipeline card: 7 registered trials from official public datasets.Report a data error.